[ahead of time] selected announcement on the 16th: the products of the two companies are listed in covid-19 pneumonia diagnosis and treatment plan (trial version 9)

Chacha Food Company Limited(002557) : the controlling shareholder intends to increase the holding of shares of the company by 30 million yuan to 60 million yuan

Chacha Food Company Limited(002557) ( Chacha Food Company Limited(002557) ) it was announced on March 16 that Huatai Group, the controlling shareholder of the company, increased its holdings of 323300 shares of the company on March 15, accounting for 0.06% of the total share capital of the company, with an increase of RMB 149967 million. Within six months from March 15, the first increase date, Huatai Group plans to continue to increase its shares in the company, with an increase amount of no less than 30 million yuan and no more than 60 million yuan (including 149967 million yuan).

Yongxing Special Materials Technology Co.Ltd(002756) : the net profit from January to February increased by about 650% year-on-year

Yongxing Special Materials Technology Co.Ltd(002756) ( Yongxing Special Materials Technology Co.Ltd(002756) ) announced on March 16 that from January to February, the company achieved an operating revenue of about 1.58 billion yuan, a year-on-year increase of about 96%, and a net profit attributable to shareholders of listed companies of about 490 million yuan, a year-on-year increase of about 650%. The company’s performance growth is mainly due to the continuous rapid development of lithium battery new energy industry, which drives the rising price of lithium carbonate. From January to February, the company’s lithium new energy business achieved an operating revenue of about 620 million yuan, a year-on-year increase of about 670%, and the net profit attributable to shareholders of listed companies was about 420 million yuan, a year-on-year increase of about 3700%.

Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) : Xuebijing injection is included in the New Coronavirus pneumonia diagnosis and treatment plan (trial version ninth)

Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) ( Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) ) March 16th announcement, in March 15th, the national health and Health Commission and the State Administration of traditional Chinese medicine jointly issued the New Coronavirus pneumonia diagnosis and treatment plan (trial version ninth). Xuebijing injection, the company’s product, is listed as the recommended medication for severe and dangerous cases in the clinical treatment period (confirmed cases).

Shandong Buchang Pharmaceuticals Co.Ltd(603858) : Xuanfei Baidu granule is listed in covid-19 pneumonia diagnosis and treatment plan (trial version 9)

Shandong Buchang Pharmaceuticals Co.Ltd(603858) ( Shandong Buchang Pharmaceuticals Co.Ltd(603858) ) March 16th announcement, recently, the office of the national health and Health Committee and the office of the State Administration of traditional Chinese medicine jointly issued the New Coronavirus pneumonia diagnosis and treatment plan (trial version ninth).

Shanxi Xinghuacun Fen Wine Factory Co.Ltd(600809) : it is proposed to invest 9.102 billion yuan in the expansion project of original wine production and energy storage

Shanxi Xinghuacun Fen Wine Factory Co.Ltd(600809) ( Shanxi Xinghuacun Fen Wine Factory Co.Ltd(600809) ) announced on March 16 that the company plans to invest 9.102 billion yuan in the construction and implementation of Fenjiu 2030 technical transformation original wine production and storage expansion project (phase I). The project covers an area of 1932 Mu and the construction period is planned to be three years. After the completion of the project, the company is expected to increase the annual output of original wine by 51000 tons and the energy storage of original wine by 134400 tons.

- Advertisment -